HUP0002212A2 - Budesonid finomeloszlású kristályos részecskéit tartalmazó készítmény és előállítása - Google Patents
Budesonid finomeloszlású kristályos részecskéit tartalmazó készítmény és előállításaInfo
- Publication number
- HUP0002212A2 HUP0002212A2 HU0002212A HUP0002212A HUP0002212A2 HU P0002212 A2 HUP0002212 A2 HU P0002212A2 HU 0002212 A HU0002212 A HU 0002212A HU P0002212 A HUP0002212 A HU P0002212A HU P0002212 A2 HUP0002212 A2 HU P0002212A2
- Authority
- HU
- Hungary
- Prior art keywords
- finely divided
- budesonide
- particles
- crystalline particles
- preparation
- Prior art date
Links
- 239000002245 particle Substances 0.000 title abstract 5
- VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 title abstract 3
- 229960004436 budesonide Drugs 0.000 title abstract 3
- 239000012530 fluid Substances 0.000 abstract 2
- 239000002904 solvent Substances 0.000 abstract 2
- 239000003085 diluting agent Substances 0.000 abstract 1
- 239000006185 dispersion Substances 0.000 abstract 1
- 238000000605 extraction Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000001953 recrystallisation Methods 0.000 abstract 1
- 208000023504 respiratory system disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
A találmány tárgyát budesonid finomeloszlású, lényegileg kristályosrészecskéi képezik, amelyek BET értéke 1 és 4,5 m2/g között van,átkristályosodási energiája 1 J/g-nál kisebb, tömeg szerinti átlagosátmérője 10 mm-nél kisebb. A találmány tárgyát képezi továbbá a fentifinomeloszlási részecskéknek vagy az azokat gyógyászatilag elfogadhatóhordozóval vagy hígítóval együtt tartalmazó gyógyszerkészítményneklégzési rendellenességek kezelésében való alkalmazása, valamint afenti finomeloszlású részecskék előállítására szolgáló eljárás. Afinomeloszlású részecskéket úgy állítják elő, hogy budesonidoldószeres oldatát és egy szuperkritikus folyadékot együtt vezetnek beegy olyan készülékbe, amelyben a hőmérsékletet és nyomást úgyszabályozzák, hogy az oldószer diszperziója és extrakciója aszuperkritikus folyadék hatására lényegileg egyidejűleg menjen végbe. Ó
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9701956A SE9701956D0 (sv) | 1997-05-23 | 1997-05-23 | New composition of matter |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0002212A2 true HUP0002212A2 (hu) | 2000-12-28 |
HUP0002212A3 HUP0002212A3 (en) | 2001-04-28 |
Family
ID=20407079
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0002212A HUP0002212A3 (en) | 1997-05-23 | 1998-05-15 | Composition comprising finely divided, crystalline particles of budesonide and preparation thereof |
Country Status (28)
Country | Link |
---|---|
US (2) | US6346523B1 (hu) |
EP (1) | EP1005328B1 (hu) |
JP (1) | JP2001525850A (hu) |
KR (1) | KR100514971B1 (hu) |
CN (1) | CN1146406C (hu) |
AR (1) | AR015820A1 (hu) |
AT (1) | ATE246492T1 (hu) |
AU (1) | AU734763B2 (hu) |
BR (1) | BR9808812A (hu) |
CA (1) | CA2290538C (hu) |
DE (1) | DE69816997T2 (hu) |
DK (1) | DK1005328T3 (hu) |
EE (1) | EE03850B1 (hu) |
ES (1) | ES2205496T3 (hu) |
HU (1) | HUP0002212A3 (hu) |
ID (1) | ID24332A (hu) |
IL (1) | IL133098A (hu) |
IS (1) | IS5254A (hu) |
NO (1) | NO995540D0 (hu) |
NZ (1) | NZ500852A (hu) |
PL (1) | PL336902A1 (hu) |
PT (1) | PT1005328E (hu) |
SE (1) | SE9701956D0 (hu) |
SK (1) | SK158799A3 (hu) |
TR (1) | TR199902880T2 (hu) |
TW (1) | TW518236B (hu) |
WO (1) | WO1998052544A1 (hu) |
ZA (1) | ZA984127B (hu) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE274341T1 (de) * | 1995-02-24 | 2004-09-15 | Elan Pharma Int Ltd | Nanopartikel-dispersionen enthaltende aerosole |
BR0108912A (pt) | 2000-03-03 | 2002-12-24 | Boehringer Ingelheim Pharma | Processamento de material por expansão-contração de solvente repetido |
CA2433169A1 (en) * | 2000-12-26 | 2002-07-04 | Takeda Chemical Industries, Ltd. | Porous substances and methods for producing the same |
GB0106403D0 (en) * | 2001-03-15 | 2001-05-02 | Pharmaceutical Profiles | Labelling of dry powder formulations for inhalation |
GB0208742D0 (en) | 2002-04-17 | 2002-05-29 | Bradford Particle Design Ltd | Particulate materials |
CA2456806C (en) * | 2001-08-08 | 2011-10-18 | Brown University Research Foundation | Methods for micronization of hydrophobic drugs |
BR0213155A (pt) * | 2001-10-10 | 2004-09-14 | Boehringer Ingelheim Pharma | Processamento de pó com fluidos gasosos pressurizados |
US20030129242A1 (en) * | 2002-01-04 | 2003-07-10 | Bosch H. William | Sterile filtered nanoparticulate formulations of budesonide and beclomethasone having tyloxapol as a surface stabilizer |
GB0216562D0 (en) * | 2002-04-25 | 2002-08-28 | Bradford Particle Design Ltd | Particulate materials |
US9339459B2 (en) | 2003-04-24 | 2016-05-17 | Nektar Therapeutics | Particulate materials |
JP2007501683A (ja) | 2003-05-22 | 2007-02-01 | エラン ファーマ インターナショナル リミテッド | γ線照射によるナノ粒子活性物質分散体の滅菌法 |
TWI359675B (en) | 2003-07-10 | 2012-03-11 | Dey L P | Bronchodilating β-agonist compositions |
US20070020299A1 (en) | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
US20070020298A1 (en) * | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid |
US20070020196A1 (en) * | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid prepared from a unit dose suspension |
DE602004023765D1 (de) * | 2004-03-12 | 2009-12-03 | Trinity College Dublin | Magnetoresistives medium |
JP2008533055A (ja) * | 2005-03-18 | 2008-08-21 | ナノマテリアルズ テクノロジー ピーティーイー リミテッド | 吸入剤 |
WO2007009164A1 (en) | 2005-07-15 | 2007-01-25 | Eiffel Technologies Limited | Method of particle formation |
EP1782839A1 (en) | 2005-11-03 | 2007-05-09 | Genetic S.p.A. | Sterilization process of Glucocorticosteroid by supercritical CO2 |
US20070185066A1 (en) * | 2005-12-20 | 2007-08-09 | Verus Pharmaceuticals, Inc. | Systems and methods for the delivery of corticosteroids |
US20070197486A1 (en) * | 2005-12-20 | 2007-08-23 | Verus Pharmaceuticals, Inc. | Methods and systems for the delivery of corticosteroids |
US20070249572A1 (en) * | 2005-12-20 | 2007-10-25 | Verus Pharmaceuticals, Inc. | Systems and methods for the delivery of corticosteroids |
US20070178049A1 (en) * | 2005-12-20 | 2007-08-02 | Verus Pharmaceuticals, Inc. | Systems and methods for the delivery of corticosteroids having an enhanced pharmacokinetic profile |
US20070160542A1 (en) * | 2005-12-20 | 2007-07-12 | Verus Pharmaceuticals, Inc. | Methods and systems for the delivery of corticosteroids having an enhanced pharmacokinetic profile |
US20070178051A1 (en) * | 2006-01-27 | 2007-08-02 | Elan Pharma International, Ltd. | Sterilized nanoparticulate glucocorticosteroid formulations |
CA2642577A1 (en) * | 2006-02-15 | 2007-08-23 | Tika Lakemedel Ab | Methods of manufacturing corticosteroid solutions |
CA2677838C (en) | 2007-02-11 | 2017-08-01 | Map Pharmaceuticals, Inc. | Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile |
US20100294986A1 (en) * | 2009-05-19 | 2010-11-25 | Massachusetts Institute Of Technology | Supercritical fluid facilitated particle formation in microfluidic systems |
US20100298602A1 (en) * | 2009-05-19 | 2010-11-25 | Massachusetts Institute Of Technology | Systems and methods for microfluidic crystallization |
CA2812263A1 (en) * | 2010-09-22 | 2012-03-29 | Map Pharmaceuticals, Inc. | Corticosteroid particles and method of production |
CN102975731B (zh) * | 2012-04-24 | 2015-08-12 | 南车南京浦镇车辆有限公司 | 轨道车辆司机室骨架与车体的安装结构 |
WO2021219230A1 (en) | 2020-04-30 | 2021-11-04 | Paolo Fiorina | Antiviral treatment |
KR102567655B1 (ko) | 2020-11-13 | 2023-08-17 | 주식회사 비츠로이엠 | 진공커패시터 및 진공커패시터 제조 방법 |
KR20230072022A (ko) | 2021-11-17 | 2023-05-24 | 주식회사 비츠로이엠 | 가변형 진공 커패시터 |
KR20230072023A (ko) | 2021-11-17 | 2023-05-24 | 주식회사 비츠로이엠 | 가변형 진공 커패시터의 나선형 전극 위치 결정구조 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1282405C (en) | 1984-05-21 | 1991-04-02 | Michael R. Violante | Method for making uniformly sized particles from water-insoluble organic compounds |
KR0132576B1 (ko) | 1988-10-05 | 1998-04-17 | 로렌스 티. 웰츠 | 항-용매 내로의 침전을 통한 미분 고형물 결정 분말의 제조 방법 |
GB9001635D0 (en) | 1990-01-24 | 1990-03-21 | Ganderton David | Aerosol carriers |
IE67187B1 (en) | 1990-06-15 | 1996-03-06 | Merck & Co Inc | A crystallization method to improve crystal structure and size |
SE9302777D0 (sv) | 1993-08-27 | 1993-08-27 | Astra Ab | Process for conditioning substances |
US5874063A (en) * | 1991-04-11 | 1999-02-23 | Astra Aktiebolag | Pharmaceutical formulation |
DE69232462T2 (de) * | 1991-12-18 | 2002-10-10 | Astrazeneca Ab | Formoterol und budesonide enthaltende zusammensetzung |
GB9313642D0 (en) * | 1993-07-01 | 1993-08-18 | Glaxo Group Ltd | Method and apparatus for the formation of particles |
SE9501384D0 (sv) | 1995-04-13 | 1995-04-13 | Astra Ab | Process for the preparation of respirable particles |
-
1997
- 1997-05-23 SE SE9701956A patent/SE9701956D0/xx unknown
-
1998
- 1998-05-15 DK DK98924697T patent/DK1005328T3/da active
- 1998-05-15 TR TR1999/02880T patent/TR199902880T2/xx unknown
- 1998-05-15 IL IL13309898A patent/IL133098A/xx not_active IP Right Cessation
- 1998-05-15 CN CNB988053381A patent/CN1146406C/zh not_active Expired - Fee Related
- 1998-05-15 ID IDW991396A patent/ID24332A/id unknown
- 1998-05-15 NZ NZ500852A patent/NZ500852A/en unknown
- 1998-05-15 AT AT98924697T patent/ATE246492T1/de not_active IP Right Cessation
- 1998-05-15 PT PT98924697T patent/PT1005328E/pt unknown
- 1998-05-15 PL PL98336902A patent/PL336902A1/xx unknown
- 1998-05-15 AU AU76800/98A patent/AU734763B2/en not_active Ceased
- 1998-05-15 EE EEP199900533A patent/EE03850B1/xx not_active IP Right Cessation
- 1998-05-15 BR BR9808812-2A patent/BR9808812A/pt not_active Application Discontinuation
- 1998-05-15 ZA ZA984127A patent/ZA984127B/xx unknown
- 1998-05-15 KR KR10-1999-7010785A patent/KR100514971B1/ko not_active IP Right Cessation
- 1998-05-15 TW TW087107532A patent/TW518236B/zh not_active IP Right Cessation
- 1998-05-15 JP JP55028498A patent/JP2001525850A/ja not_active Ceased
- 1998-05-15 CA CA002290538A patent/CA2290538C/en not_active Expired - Fee Related
- 1998-05-15 SK SK1587-99A patent/SK158799A3/sk unknown
- 1998-05-15 EP EP98924697A patent/EP1005328B1/en not_active Expired - Lifetime
- 1998-05-15 US US09/091,453 patent/US6346523B1/en not_active Expired - Fee Related
- 1998-05-15 HU HU0002212A patent/HUP0002212A3/hu unknown
- 1998-05-15 DE DE69816997T patent/DE69816997T2/de not_active Expired - Lifetime
- 1998-05-15 ES ES98924697T patent/ES2205496T3/es not_active Expired - Lifetime
- 1998-05-15 WO PCT/SE1998/000908 patent/WO1998052544A1/en active IP Right Grant
- 1998-05-22 AR ARP980102400A patent/AR015820A1/es not_active Application Discontinuation
-
1999
- 1999-11-12 NO NO995540A patent/NO995540D0/no not_active Application Discontinuation
- 1999-11-18 IS IS5254A patent/IS5254A/is unknown
-
2001
- 2001-11-06 US US09/992,940 patent/US6468994B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0002212A2 (hu) | Budesonid finomeloszlású kristályos részecskéit tartalmazó készítmény és előállítása | |
BG106762A (en) | Polycycloalkylpurines as adenosine receptor antagonists | |
AU2001236904A1 (en) | Deep brain stimulation system for the treatment of parkinson's disease or other disorders | |
HUP0301167A3 (en) | Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders, process for their preparation, pharmaceutical compositions containing them and their use | |
HUP0401086A3 (en) | 4 (phenyl-piperazinyl-methyl) benzamide derivatives and their use for preparation of pharmaceutical compositions for the treatment of pain, anxiety or gastrointestinal disorders and process for preparation the compounds | |
SI0751129T1 (en) | Substituted dihydrodibenzo(b,f)azepines, method for their preparation, their use in the treatment of some central nervous system disorders, and pharmaceutical compositions containing them | |
HUP0002296A2 (hu) | Sertralinsók és a sertralin elnyújtott felszabadulását biztosító dózisformák | |
WO2003092580A3 (en) | Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor | |
AU4048989A (en) | Alkoxy-4(1h)-pyridone derivatives, processes for preparing them and their use as drugs | |
CA2401033A1 (en) | 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses | |
PL312225A1 (en) | Novel chemical compounds exhibiting pde iv inhibiting activity | |
IL115073A (en) | Use of 5-substituted pyridine-and hexahydroquinoline-3-carboxylic acid derivatives for the preparation of pharmaceutical compositions for the treatment of disorders of the central nervous system some such novel compounds their preparation and pharmaceutical compositions containing them | |
DE58900636D1 (de) | Indolocarbazol-derivate, verfahren zu deren herstellung und deren verwendung als arzneimittel. | |
ATE353328T1 (de) | Adenosin rezeptor antagonisten sowie methoden zu deren herstellung und verwendung | |
ATE245445T1 (de) | Suspension enthaltend ein epi-hne protein, verfahren zu ihrer herstellung, daraus hergestelltes trockenpulveraerosol, arzneimittelzusammensetzungen enthaltend diese suspension oder dieses aerosol und ihre verwendungen | |
WO2004011464A3 (fr) | Nouvelles pyrazolo[1,5-a]-1,3,5-triazines substituees et leurs analogiques, compositions pharmaceutiques les contenant, utilisation a titre de medicament et procedes pour leur preparation | |
WO2002083149A1 (fr) | Medicaments contenant un acide phosphatique cyclique et favorisant la proliferation, la differentiation et/ou la survie de cellules gliales | |
AU4333893A (en) | Use of guanosine and its precursors and derivatives in the manufacture of drugs for the treatment of brain dysfunction | |
ES2009689A6 (es) | Procedimiento para preparar derivados de 3-piperidina-carbaldehido-oxima. | |
DE69815306D1 (de) | Valnoctamid-stereoisomere, eine methode zu ihrer herstellung und abtrennung und ihre anwendungen | |
HUP0100044A1 (hu) | A humán Ha-ras gén egy szakaszával komplementer, módosított antiszensz oligonukleotidok | |
WO1999020291A3 (en) | Pharmaceutical grade ginkgo biloba | |
ZA898274B (en) | 2-aminocarboxylic acids and their derivatives,processes for their preparation and their use as medicaments | |
WO1989000571A3 (en) | Bicyclic compounds, their use as pharmaceuticals, their preparation, and intermediates useful in their preparation | |
AU2003294952A8 (en) | 3,3-dimethyl-8-oxoisoquinolines for medical purposes, methods for the production thereof, medicaments containing said compounds and the use of the same |